| Ytd | -19.76% | |
| 1y | 1.45% |
| Open | 14.74 | Prev Close | 14.75 | Low | 14.38 | High | 14.80 | Mkt Cap | 3.68B |
| Vol | 109.75K | Avg Vol | 2.14M | EPS | 0.39 | P/E | 37.82 | Forward P/E | 35.71 |
| Beta | 1.17 | Short Ratio | 3.25 | Inst. Own | 51.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 14.05 | 200-d Avg | 15.46 | 1yr Est | 21.00 |
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 21, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 5
The partnership unifies what happens in the sky with what's stored on the drone in a single investig
Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal d
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript
Reduces investigative workloads from weeks to minutes accelerating investigations like never before
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten
Cellebrite Announces Upcoming Investor Events on June 10, 2026 PR Newswire TYSONS CORNER, Va. and PE
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of exp
TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite DI NASDAQ: CLBT executives said the company is seeing broader customer adoption of its di
Cognyte and Cellebrite are riding AI-driven investigative demand - dig into their growth, profitabil
Cellebrite DI NASDAQ: CLBT executives said the digital investigations company is seeing renewed mome
Cellebrite DI Ltd. (CLBT) Presents at J.P.
Cellebrite delivered strong Q1 2026 results, with 19% revenue growth and notable subscription and AR
Cellebrite DI Ltd. (CLBT) Q1 2026 Earnings Call Transcript
Cellebrite DI NASDAQ: CLBT reported first-quarter 2026 results that management said met or exceeded
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.12 per share, beating the Zacks Con
First-Quarter ARR Growth of 21% and TTM Free Cash Flow Margin of 32% Q2 Outlook Highlights ARR Accel
On Thursday, 930 stocks hit new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.